Lipoteichoic acid selectively induces the ERK signaling pathway in the cornea.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 12091427)

Published in Invest Ophthalmol Vis Sci on July 01, 2002

Authors

Lingtao You1, Friedrich E Kruse, Susanne Bacher, M Lienhard Schmitz

Author Affiliations

1: Department of Ophthalmology, University of Heidelberg Medical School, INF 400, 69120 Heidelberg, Germany.

Articles by these authors

Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol (2002) 3.24

Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J Biol Chem (2004) 2.38

Identification and characterization of limbal stem cells. Exp Eye Res (2005) 2.38

Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity. J Biol Chem (2004) 2.29

Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci (2004) 2.27

Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest Ophthalmol Vis Sci (2007) 2.05

SUMOylation-dependent localization of IKKepsilon in PML nuclear bodies is essential for protection against DNA-damage-triggered cell death. Mol Cell (2010) 1.79

A redox-regulated SUMO/acetylation switch of HIPK2 controls the survival threshold to oxidative stress. Mol Cell (2012) 1.73

Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucoma. Am J Hum Genet (2009) 1.71

Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci (2008) 1.71

Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import. J Immunol (2004) 1.69

Descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty. Am J Ophthalmol (2012) 1.68

GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial. Ophthalmology (2009) 1.67

Pressure-induced interlamellar stromal keratitis after laser in situ keratomileusis. Cornea (2011) 1.66

Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea (2006) 1.66

Retinal nerve fiber layer thickness in normals measured by spectral domain OCT. J Glaucoma (2010) 1.55

Histologic analysis of descemet stripping in posterior lamellar keratoplasty. Arch Ophthalmol (2008) 1.52

Reproducibility of graft preparations in Descemet's membrane endothelial keratoplasty. Ophthalmology (2013) 1.51

Autoregulatory feedback loops terminating the NF-kappaB response. Trends Biochem Sci (2009) 1.46

Tumor-associated lymphangiogenesis in the development of conjunctival squamous cell carcinoma. Ophthalmology (2010) 1.46

Corneal limbal microenvironment can induce transdifferentiation of hair follicle stem cells into corneal epithelial-like cells. Stem Cells (2009) 1.46

Correlation between local glaucomatous visual field defects and loss of nerve fiber layer thickness measured with polarimetry and spectral domain OCT. Invest Ophthalmol Vis Sci (2009) 1.41

Surgery-related factors influencing corneal neovascularization after low-risk keratoplasty. Am J Ophthalmol (2006) 1.41

Tumors of the lacrimal drainage system. Orbit (2010) 1.40

Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients. Am J Pathol (2008) 1.38

Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2. Mol Cell (2006) 1.37

Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation. EMBO J (2006) 1.37

The Pathogenesis of floppy eyelid syndrome: involvement of matrix metalloproteinases in elastic fiber degradation. Ophthalmology (2005) 1.36

NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer. Curr Med Chem (2007) 1.34

HIPK2: a versatile switchboard regulating the transcription machinery and cell death. Cell Cycle (2007) 1.34

Differential gene expression in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci (2005) 1.33

HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells. Cancer Res (2003) 1.32

An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response. Nat Cell Biol (2008) 1.29

Split cornea transplantation for 2 recipients: a new strategy to reduce corneal tissue cost and shortage. Ophthalmology (2010) 1.29

Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade. Am J Pathol (2007) 1.29

Inducible phosphorylation of NF-kappa B p65 at serine 468 by T cell costimulation is mediated by IKK epsilon. J Biol Chem (2006) 1.28

Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. Arch Ophthalmol (2008) 1.27

Critical role of NF-kappaB and stress-activated protein kinases in steroid unresponsiveness. FASEB J (2002) 1.24

From hair to cornea: toward the therapeutic use of hair follicle-derived stem cells in the treatment of limbal stem cell deficiency. Stem Cells (2011) 1.22

Specification of the NF-kappaB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKK epsilon. Nucleic Acids Res (2010) 1.20

PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains. Cancer Res (2003) 1.19

Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material. Invest Ophthalmol Vis Sci (2006) 1.18

Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma. Am J Pathol (2010) 1.15

Genome-wide association study with DNA pooling identifies variants at CNTNAP2 associated with pseudoexfoliation syndrome. Eur J Hum Genet (2010) 1.14

Corneal higher-order aberrations after Descemet's membrane endothelial keratoplasty. Ophthalmology (2011) 1.14

The K252a derivatives, inhibitors for the PAK/MLK kinase family selectively block the growth of RAS transformants. Cancer J (2002) 1.12

The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex. J Biol Chem (2002) 1.11

Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2. EMBO J (2006) 1.10

Preservation of the limbal stem cell phenotype by appropriate culture techniques. Invest Ophthalmol Vis Sci (2009) 1.09

Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3 signaling. Am J Pathol (2005) 1.09

Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci (2011) 1.07

Pentacam-based big bubble deep anterior lamellar keratoplasty in patients with keratoconus. Cornea (2012) 1.07

Split cornea transplantation for 2 recipients - review of the first 100 consecutive patients. Am J Ophthalmol (2011) 1.07

Src homology 2 domain-containing leukocyte phosphoprotein of 76 kDa and phospholipase C gamma 1 are required for NF-kappa B activation and lipid raft recruitment of protein kinase C theta induced by T cell costimulation. J Immunol (2003) 1.06

Longitudinal analysis of progression in glaucoma using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci (2013) 1.05

Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension. Invest Ophthalmol Vis Sci (2009) 1.04

IL-17 reduces TNF-induced Rantes and VCAM-1 expression. Cytokine (2005) 1.04

NF-kappaB activation pathways induced by T cell costimulation. FASEB J (2003) 1.03

LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma. Ophthalmology (2012) 1.02

Safety profile of topical VEGF neutralization at the cornea. Invest Ophthalmol Vis Sci (2009) 1.02

Combination of transepithelial phototherapeutic keratectomy and autologous serum eyedrops for treatment of recurrent corneal erosions. J Cataract Refract Surg (2005) 1.02

Homocysteine in tear fluid of patients with pseudoexfoliation glaucoma. J Glaucoma (2007) 1.02

Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody). Cornea (2008) 1.02

High expression of chemokines Gro-alpha (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in inflamed human corneas in vivo. Arch Ophthalmol (2003) 1.02

HIPK2 kinase activity depends on cis-autophosphorylation of its activation loop. J Mol Cell Biol (2012) 1.02

The prostaglandin transporter OATP2A1 is expressed in human ocular tissues and transports the antiglaucoma prostanoid latanoprost. Invest Ophthalmol Vis Sci (2009) 1.01

Exploring functional candidate genes for genetic association in german patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci (2009) 1.00

The normal human choroid is endowed with a significant number of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1)-positive macrophages. Invest Ophthalmol Vis Sci (2008) 0.98

Tear film osmolarity measurements in dry eye disease using electrical impedance technology. Cornea (2011) 0.98

The marine product cephalostatin 1 activates an endoplasmic reticulum stress-specific and apoptosome-independent apoptotic signaling pathway. J Biol Chem (2006) 0.98

Adhesion structures of amniotic membranes integrated into human corneas. Invest Ophthalmol Vis Sci (2006) 0.97

Impaired cytoprotective mechanisms in eyes with pseudoexfoliation syndrome/glaucoma. Invest Ophthalmol Vis Sci (2007) 0.97

Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs. Cornea (2012) 0.96

Selective upregulation of the A3 adenosine receptor in eyes with pseudoexfoliation syndrome and glaucoma. Invest Ophthalmol Vis Sci (2005) 0.96

Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva. Ophthalmology (2011) 0.96

Descemet membrane endothelial keratoplasty combined with phacoemulsification and intraocular lens implantation: advanced triple procedure. Am J Ophthalmol (2012) 0.96

C677T variant in the methylentetrahydrofolate reductase gene is a genetic risk factor for primary open-angle glaucoma. Am J Ophthalmol (2005) 0.95

Integration of the activation of the human hyaluronan synthase 2 gene promoter by common cofactors of the transcription factors retinoic acid receptor and nuclear factor kappaB. J Biol Chem (2007) 0.95

The NF-kappaB pathway as a potential target for autoimmune disease therapy. Curr Pharm Des (2004) 0.95

Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway. Invest Ophthalmol Vis Sci (2002) 0.95

Histopathology and ultrastructure of human corneas after amniotic membrane transplantation. Arch Ophthalmol (2006) 0.94

Stem cell-based therapy for corneal epithelial reconstruction: present and future. Can J Ophthalmol (2013) 0.94

Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma. Am J Ophthalmol (2004) 0.94

Donor tissue culture conditions and outcome after descemet membrane endothelial keratoplasty. Am J Ophthalmol (2011) 0.94

Incensole acetate, a novel anti-inflammatory compound isolated from Boswellia resin, inhibits nuclear factor-kappa B activation. Mol Pharmacol (2007) 0.93

Cyclin-dependent kinase 6 phosphorylates NF-κB P65 at serine 536 and contributes to the regulation of inflammatory gene expression. PLoS One (2012) 0.93

Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension? Ophthalmology (2009) 0.92

Fungal interface keratitis by Candida orthopsilosis following deep anterior lamellar keratoplasty. BMJ Case Rep (2013) 0.92

Covalent modification of human homeodomain interacting protein kinase 2 by SUMO-1 at lysine 25 affects its stability. Biochem Biophys Res Commun (2005) 0.92

Roscovitine-activated HIP2 kinase induces phosphorylation of wt p53 at Ser-46 in human MCF-7 breast cancer cells. J Cell Biochem (2007) 0.92

Integration patterns of cryopreserved amniotic membranes into the human cornea. Ophthalmology (2006) 0.92

Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation. Invest Ophthalmol Vis Sci (2008) 0.91

Microbubble incision as a new rescue technique for big-bubble deep anterior lamellar keratoplasty with failed bubble formation. Cornea (2013) 0.91

Role of CREB1 and NF{kappa}B-p65 in the down-regulation of renin gene expression by tumor necrosis factor {alpha}. J Biol Chem (2005) 0.91

Interleukin-1 beta-induced expression of the prostaglandin E-receptor subtype EP3 in U373 astrocytoma cells depends on protein kinase C and nuclear factor-kappaB. J Neurochem (2006) 0.90

The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB. Nucleic Acids Res (2012) 0.90

Histopathological changes after deep anterior lamellar keratoplasty using the 'big-bubble technique'. Acta Ophthalmol (2011) 0.89

Apolipoprotein E genotypes in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. J Glaucoma (2010) 0.89

Comparative analysis of T-cell costimulation and CD43 activation reveals novel signaling pathways and target genes. Blood (2004) 0.89